allakos.com (ALLK) Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization
The historical EV/EBITDA chart for Allakos Inc. (ALLK) is currently at , which is attributed to the absence of commercial products and market-based pricing. Allakos Inc. (ALLK) is developing unique antibodies to combat gastritis and severe allergies by blocking the Siglec-8 receptor. Since the business is in the clinical testing stage, its stability relies exclusively on existing cash reserves.
allakos.com - analytical breakdowns and key metrics (ALLK)
- current price and projected stock value:
- market capitalization details:
- book value of equity indicators:
- debt level and financial liquidity data:
- business earnings and investment ratios data:
ALLK - Company Net Income|Projected Future Earnings Allakos Inc.|ALLK - P/E Multiple|Future Price to Earnings Allakos|ALLK - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization ALLK|ALLK - Profit before interest, taxes and amortization|Earnings per share for the last twelve months Allakos|ALLK - Net earnings per share for the last four quarters|Year-over-year net earnings per share growth for the last 12 months allakos.com|ALLK - Earnings per share increase in current year|Earnings growth forecast for next year Allakos Inc.
Initial company analysis:Allakos Therapeutics ALLK
Allakos Inc. specializes in innovative mast cell control for the treatment of severe allergies, which requires significant capital expenditures. The EV/EBITDA metric assesses the enterprise value, including net debt, relative to operating profit before interest, taxes, depreciation, and amortization, revealing the actual value of the assets. By analyzing the EV/EBITDA multiple trend, an investor determines the balance between market expectations and fundamental returns during periods of high volatility.
Competitors of Allakos Inc.
EV/EBITDA Multiple ARGX (Argenx)|Total Company Value to Operating Income Before Depreciation Ratio BioNTech Pharma (BNTX)|ABVX - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|admabiologics.com (ADMA) - Enterprise Value to EBITDA Ratio|Protagonist (PTGX) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio Immunovant Inc|Enterprise Value to EBITDA Ratio KNSA|EV/EBITDA Multiple Grifols Biemat|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Adaptive Biotechnologies (ADPT)|celldex.com - Enterprise Value to Operating Income Before Depreciation|EV/EBITDA Multiple AUPH (Aurinia Pharmaceuticals Inc.)|BioCryst Pharmaceuticals, Inc. (BCRX) - Company Value to EBITDA|Vera Pharma - EV/EBITDA Multiple|DNTH - EV/EBITDA Multiple|Pharvaris N.V. (PHVS) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|ABCL (AbCellera) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Tourmaline Bio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization PGEN|EV/EBITDA Multiple PHAR|EV/EBITDA Multiple Nektar Corp (NKTR)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Upstream Bio Inc UPB|EV/EBITDA Multiple zenasbio.com ZBIO|IMNM - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to EBITDA Gossamer Bio Inc|KalVista Pharmaceuticals Inc (KALV) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|SEPN - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to EBITDA Ratio PVLA|SVRA: Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple RIGL|Total Company Value to Operating Income Before Depreciation Ratio AnaptysBio Inc|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Astria Pharma ATXS|ENGN: Enterprise Value to Operating Income Before Depreciation|RAPT Therapeutics - EV/EBITDA Multiple|Aerovate Therapeutics Inc (JBIO) - Enterprise Value to EBITDA Ratio|ACRS (Aclaris Therapeutics, Inc.) - Enterprise Value to EBITDA Ratio|KYTX - Total Company Value to Operating Income Before Depreciation Ratio|TLSA (Tiziana Life Sciences PLC) - EV/EBITDA Multiple|EV/EBITDA Multiple Cabaletta Bio Inc|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Ventyx Biosciences (VTYX)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization THTX (theratech.com)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Avalo Therapeutics AVTX|Eledon Pharmaceuticals Inc. - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|AGEN - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|CLYM - EV/EBITDA Multiple|Zura Bio (ZURA) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to Operating Income Before Depreciation Ratio ATYR (atyrpharma.com)|ADAG (Adagene Inc) - EV/EBITDA Multiple|IMA: Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple STTK|EV/EBITDA Multiple equilliumbio.com (EQ)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Connect Biopharma Holdings Limited CNTB|Business Value to Operating Income Before Depreciation IMUX|ATRA - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|InflaRx N.V. (IFRX) - Enterprise Value to EBITDA Ratio|XFOR: EV/EBITDA Multiple|Adicet Bio, Inc. (ACET) - EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio CELU|INMB: Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple BRNS|Total Company Value to Operating Income Before Depreciation Ratio Kezar Life Sciences Inc.|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization SAB Biotherapeutics, Inc SABS|AKTX - Enterprise Value to EBITDA Ratio|ENLV - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Q32 Bio Inc. (QTTB) - Enterprise Value to EBITDA Ratio|GOVX (GeoVax) - Enterprise Value to EBITDA Ratio|Edesa Biotech Inc (EDSA) - EV/EBITDA Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization iBio Corp|Enterprise Value to Operating Income Before Depreciation CARM (Carisma Tx)|EV/EBITDA Multiple XTLB|BOLT - Company Value to EBITDA|EV/EBITDA Multiple HCWB (HCW Biologics)|EV/EBITDA Multiple Aptevo Therapeutics, Inc. APVO|AIM - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|ADTX: Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|GRI Bio, Inc. (GRI) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|XRTX (xortx.com) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|HIND (Vyome Holdings) - EV/EBITDA Multiple|EV/EBITDA Multiple Revelation Biosciences Inc|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Indaptus (INDP)|EV/EBITDA Multiple BiondVax Pharmaceuticals (SCNI)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization CalciMedica CALI|Affimed NV (AFMD) - Company Value to EBITDA|HOOK - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Total Company Value to Operating Income Before Depreciation Ratio IGM Biosciences, Inc. IGMS|ITOS (iTeos) - Enterprise Value to EBITDA Ratio|Ocean Biomedical Corp - Business Value to Operating Income Before Depreciation|TCBP (TC Biopharm) - EV/EBITDA Multiple|thirdharmonicbio.com (THRD) - Total Company Value to Operating Income Before Depreciation Ratio
